MDMA-Assisted Psychotherapy for Anxiety Associated With a Life-Threatening Illness

NCT02427568 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Anxiety

Interventions

DRUG: Midomafetamine HCl
DRUG: Placebo
BEHAVIORAL: Therapy

Sponsor

Resilient Pharmaceuticals